We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 27 september 2018

Gene Therapy - Table of Contents alert Volume 25 Issue 6

If you are unable to see the message below, click here to view.
Gene Therapy

Advertisement
 
TABLE OF CONTENTS

Volume 25, Issue 6

In this issue
Comment
Article
Brief Communication
Correction
Also new
AOP
 

Comment

Diabetic complication could get a gene therapy boost

Julio Enrique Castañeda-Delgado

Gene Therapy 2018 25 :401 - 401; August 10, 2018; 10.1038/s41434-018-0037-4

 

Abstract | Full Text

Article

Serotype survey of AAV gene delivery via subconjunctival injection in mice

Liujiang Song, Telmo Llanga, Laura M. Conatser, Violeta Zaric, Brian C. Gilger et al.

Gene Therapy 2018 25 :402 - 414; August 02, 2018; 10.1038/s41434-018-0035-6

 

Abstract | Full Text

Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system

Bas Bosma, Francois du Plessis, Erich Ehlert, Bart Nijmeijer, Martin de Haan et al.

Gene Therapy 2018 25 :415 - 424; August 01, 2018; 10.1038/s41434-018-0034-7

 

Abstract | Full Text

Brief Communication

Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats

Rongfeng Shi, Weishuai Lian, Shilong Han, Chuanwu Cao, Yinpeng Jin et al.

Gene Therapy 2018 25 :425 - 438; June 28, 2018; 10.1038/s41434-018-0027-6

 

Abstract | Full Text

Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth

Laura Sánchez-Hernández, Justino Hernández-Soto, Paula Vergara, Rosa O. González & José Segovia

Gene Therapy 2018 25 :439 - 449; June 25, 2018; 10.1038/s41434-018-0020-0

 

Abstract | Full Text

Correction

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

A. Georgiadis, Y. Duran, J. Ribeiro, L. Abelleira-Hervas, S. J. Robbie et al.

Gene Therapy 2018 25 :450 - 450; July 25, 2018; 10.1038/s41434-018-0031-x

 

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature